Equities research analysts at Citigroup Inc. upped their target price on shares of Envision Healthcare Holdings (NASDAQ:EVHC) from $37.00 to $170.00 in a research note issued to investors on Tuesday, Stock Ratings News reports. The firm currently has a “buy” rating on the stock. Citigroup Inc.’s target price would suggest a potential upside of 427.13% from the stock’s previous close.
Envision Healthcare Holdings (NASDAQ:EVHC) traded down 1.44% during mid-day trading on Tuesday, hitting $31.785. The stock had a trading volume of 140,571 shares. Envision Healthcare Holdings has a 52-week low of $24.62 and a 52-week high of $32.54. The stock’s 50-day moving average is $29.13 and its 200-day moving average is $28.01. The company has a market cap of $5.733 billion and a price-to-earnings ratio of 424.34.
Envision Healthcare Holdings (NASDAQ:EVHC) last posted its quarterly earnings results on Wednesday, November 13th. The company reported $0.13 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.13. The company had revenue of $955.90 million for the quarter, compared to the consensus estimate of $950.22 million. Envision Healthcare Holdings’s revenue was up 16.5% compared to the same quarter last year. Analysts expect that Envision Healthcare Holdings will post $0.45 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG raised their price target on shares of Envision Healthcare Holdings from $32.00 to $37.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Barclays raised their price target on shares of Envision Healthcare Holdings from $32.00 to $33.00 in a research note to investors on Friday, November 15th. They now have an “overweight” rating on the stock. Finally, analysts at Piper Jaffray raised their price target on shares of Envision Healthcare Holdings from $32.00 to $33.00 in a research note to investors on Thursday, November 14th. They now have an “overweight” rating on the stock. Two analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Envision Healthcare Holdings currently has a consensus rating of “Buy” and a consensus price target of $44.50.
Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.